Clinical trial
Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients
NCT00133978 · Daren K. Heyland, Other · Completed
Key facts
| NCT number | NCT00133978 |
|---|---|
| Title | Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients |
| Official title | REducing Deaths Due to OXidative Stress The REDOXS© Study |
| Acronym | REDOXS |
| Lead sponsor | Daren K. Heyland, Other |
| Collaborators | Fresenius Kabi Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Critical Illness, Sepsis, Multiple Organ Failure |
| Intervention type | Other |
| Interventions | Glutamine, Antioxidants, Glutamine + Antioxidants, Placebo |
| Enrollment | 1,223 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2011 |
| Completion | May 1, 2012 |
| First posted | Aug 24, 2005 |
| Last update posted | Jan 7, 2021 |
| Countries | Belgium, Canada, Germany, Switzerland, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: